View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
April 18, 2011

New Test to Identify Cancer Patients Who Could Benefit From Diabetes Drug

Scientists from the University of Manchester in the UK and Thomas Jefferson University in the US have developed a test to identify breast cancer patients who would benefit from treatment with 10p-a-day diabetes drug metformin. A team at the University of Manchester's Breakthrough Breas

By cms admin

Scientists from the University of Manchester in the UK and Thomas Jefferson University in the US have developed a test to identify breast cancer patients who would benefit from treatment with 10p-a-day diabetes drug metformin.

A team at the University of Manchester’s Breakthrough Breast Cancer Research Unit grew cancer cells on high-energy foods such as lactates and ketones, identifying the expressing genes and then developing a gene signature based on it.

“The food cancer cells consume is crucial to how well a patient does and what treatment they need,” said Professor Michael Lisanti of the Breakthrough Breast
Cancer Research Unit.

Tumours that consume high-energy food are difficult to treat. Metformin, however, reduces this fuel supply.

The team examined 219 breast cancer patients and, based on the ‘food’ cancer cells method, predicted which patients show poor prognosis and could benefit from metformin.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management